These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12395151)

  • 1. Physiological effects of human growth hormone produced after hydrodynamic gene transfer of a plasmid vector containing the human ubiquitin promotor.
    Dagnaes-Hansen F; Holst HU; Søndergaard M; Vorup-Jensen T; Flyvbjerg A; Jensen UB; Jensen TG
    J Mol Med (Berl); 2002 Oct; 80(10):665-70. PubMed ID: 12395151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term human growth hormone expression and partial phenotypic correction by plasmid-based gene therapy in an animal model of isolated growth hormone deficiency.
    Oliveira NA; Cecchi CR; Higuti E; Oliveira JE; Jensen TG; Bartolini P; Peroni CN
    J Gene Med; 2010 Jul; 12(7):580-5. PubMed ID: 20603861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects on kidney and liver growth of a non-viral hGH-expression vector in hypophysectomized mice.
    Khamaisi M; Søndergaard M; Segev Y; Dagnaes-Hansen F; Jensen TG; Landau D; Raz I; Flyvbjerg A
    Growth Horm IGF Res; 2007 Aug; 17(4):279-87. PubMed ID: 17392003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of growth in hypophysectomized mice using hydrodynamic transfer of the human growth hormone gene.
    Sondergaard M; Dagnaes-Hansen F; Flyvbjerg A; Jensen TG
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E427-32. PubMed ID: 12657568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine.
    Anwer K; Shi M; French MF; Muller SR; Chen W; Liu Q; Proctor BL; Wang J; Mumper RJ; Singhal A; Rolland AP; Alila HW
    Hum Gene Ther; 1998 Mar; 9(5):659-70. PubMed ID: 9551614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
    Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
    Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX.
    Schüttrumpf J; Milanov P; Abriss D; Roth S; Tonn T; Seifried E
    Hum Gene Ther; 2011 Jan; 22(1):101-6. PubMed ID: 20677911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
    Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
    Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human growth hormone fusion genes in cultured lung endothelial cells and in the lungs of mice.
    Brigham KL; Meyrick B; Christman B; Conary JT; King G; Berry LC; Magnuson MA
    Am J Respir Cell Mol Biol; 1993 Feb; 8(2):209-13. PubMed ID: 7678969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of gene expression after plasmid DNA gene transfer to the liver.
    Herweijer H; Zhang G; Subbotin VM; Budker V; Williams P; Wolff JA
    J Gene Med; 2001; 3(3):280-91. PubMed ID: 11437333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors.
    Yazawa H; Murakami T; Li HM; Back T; Kurosaka K; Suzuki Y; Shorts L; Akiyama Y; Maruyama K; Parsoneault E; Wiltrout RH; Watanabe M
    Cancer Gene Ther; 2006 Nov; 13(11):993-1001. PubMed ID: 16763608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes.
    Croze F; Prud'homme GJ
    J Gene Med; 2003 May; 5(5):425-37. PubMed ID: 12731091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of hepatocyte-specific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer.
    Jacobs F; Snoeys J; Feng Y; Van Craeyveld E; Lievens J; Armentano D; Cheng SH; De Geest B
    Gene Ther; 2008 Apr; 15(8):594-603. PubMed ID: 18288213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrodynamic plasmid DNA gene therapy model in liver transplantation.
    Tsoulfas G; Takahashi Y; Liu D; Yagnik G; Wu T; Murase N; Geller DA
    J Surg Res; 2006 Oct; 135(2):242-9. PubMed ID: 16926028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery.
    Wooddell CI; Reppen T; Wolff JA; Herweijer H
    J Gene Med; 2008 May; 10(5):551-63. PubMed ID: 18330848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of monoclonal antibodies by genetic immunization.
    Barry MA; Barry ME; Johnston SA
    Biotechniques; 1994 Apr; 16(4):616-8, 620. PubMed ID: 8024780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of mouse acute colitis by naked hepatocyte growth factor gene transfer into the liver.
    Hanawa T; Suzuki K; Kawauchi Y; Takamura M; Yoneyama H; Han GD; Kawachi H; Shimizu F; Asakura H; Miyazaki J; Maruyama H; Aoyagi Y
    J Gene Med; 2006 May; 8(5):623-35. PubMed ID: 16479533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
    Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F
    Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains.
    Barr D; Tubb J; Ferguson D; Scaria A; Lieber A; Wilson C; Perkins J; Kay MA
    Gene Ther; 1995 Mar; 2(2):151-5. PubMed ID: 7719932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
    Kachi S; Esumi N; Zack DJ; Campochiaro PA
    Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.